GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogened SA (WAR:BGD) » Definitions » YoY Rev. per Sh. Growth

Biogened (WAR:BGD) YoY Rev. per Sh. Growth : 25.09% (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Biogened YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Biogened's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was 25.09%.

Biogened's Revenue per Share for the three months ended in Jun. 2024 was zł12.50.

Biogened YoY Rev. per Sh. Growth Historical Data

The historical data trend for Biogened's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogened YoY Rev. per Sh. Growth Chart

Biogened Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.89 3.64 35.15 21.89 20.02

Biogened Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.01 10.89 18.85 15.85 25.09

Biogened YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Biogened's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(38.909-32.418)/ | 32.418 |
=20.02 %

Biogened's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=(Revenue per Share (Q: Jun. 2024 )-Revenue per Share (Q: Jun. 2023 )) / | Revenue per Share (Q: Jun. 2023 )) |
=(12.5-9.993)/ | 9.993 |
=25.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Biogened's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogened Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogened SA (WAR:BGD) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
WAR:HMP WAR:CBD WAR:MDB ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
N/A
Address
Ulica Pojezierska 99, Lodz, POL, 91-342
Website
http://www.biogened.pl
Biogened SA is a Polish cosmetic company. The company defined its key areas of activity, concentrated its efforts on the development of neurological and psychiatric products. It also develops, produces and distributes ingredients, safe and effective dermo cosmetics under the Dermedic brand.

Biogened Headlines

No Headlines